Sydney A. Gilman - Jul 28, 2021 Form 4 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role
VP, Regulatory Affairs
Signature
/s/ Amy Culbert, attorney-in-fact
Stock symbol
DMAC
Transactions as of
Jul 28, 2021
Transactions value $
$0
Form type
4
Date filed
7/29/2021, 09:18 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DMAC Voting Common Shares, no par value per share 0 Jul 28, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DMAC Stock Option (right to buy) Award $0 +25K $0.00 25K Jul 28, 2021 Common Shares 25K $5.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests in sixteen nearly equal quarterly installments over four years.